Assessment of global coagulation function under treatment with emicizumab concomitantly with bypassing agents in haemophilia A with inhibitor (UNEBI Study): multicentre open-label non-randomised clinical trial
Takashi Suzuki,
Kenji Nishio,
Tadashi Matsushita,
Kenichi Ogiwara,
Masashi Taki,
Hideyuki Takedani,
Kagehiro Amano,
Masanori Matsumoto,
Midori Shima,
Masato Kasahara,
Keiji Nogami
Affiliations
Takashi Suzuki
Blood Coagulation, Medical Corporation Foundation Ogikubo Hospital, Suginami-ku, Japan
Kenji Nishio
General Medicine, Nara Medical University, Kashihara, Japan
Tadashi Matsushita
Blood Transfusion Service, Nagoya University Hospital, Nagoya, Japan
Kenichi Ogiwara
Pediatrics, Nara Medical University, Kashihara, Japan
Masashi Taki
Pediatrics, Sei Marianna University School of Medicine Yokohama Seibu Hospital, Yokohama, Japan
Hideyuki Takedani
Joint Surgery, IMSUT Hospital, Minato-ku, Japan
Kagehiro Amano
Laboratory Medicine, Tokyo Medical University, Shinjuku-ku, Japan
Masanori Matsumoto
Blood Transfusion Medicine, Nara Medical University, Kashihara, Japan
Midori Shima
Pediatrics, Nara Medical University, Kashihara, Japan
Masato Kasahara
Institute for Clinical and Translational Science, Nara Medical University, Kashihara, Japan
Keiji Nogami
Pediatrics, Nara Medical University, Kashihara, Japan
